Company: SCLXW
Filing Date: 2025-05-14
Form Type: 424B3
Source: 0001193125-25-119831
Chunk: 31

Company: Scilex Holding Co
Filing Date: 2025-05-14
Form: 424B3
Chunk 31
---
 of Common Stock offered by the Selling Stockholder | Up to 6,685,714 shares of our Common Stock, consisting of (i) 6,500,000 Penny Warrant Shares and (ii) 185,714 Issued Shares. |

| Shares of Common Stock outstanding before this Offering(1) | 6,951,671 shares of Common Stock (as of March 31, 2025). |

| Shares of Common Stock outstanding after the Offering and giving effect to the issuance of 6,500,000 shares of Common Stock | 13,451,671 shares of Common Stock (based on total shares outstanding as of March 31, 2025). |

| Terms of the Offering | The Selling Stockholder will determine when and how it will dispose of any shares of Common Stock registered under this prospectus for resale. |

| Use of proceeds | We will not receive any proceeds from the sale of shares of Common Stock by the Selling Stockholder. However, to the extent the Penny Warrants are exercised for cash, if at all, we will receive the exercise price of the Penny Warrants in an       
 amount of up to an aggregate of $65,000, assuming the exercise in full of the remaining Penny Warrants. Each Penny Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $0.01 per share. We currently intend to use 
 the proceeds (if any) from the exercise of the Penny Warrants for cash for working capital and general corporate purposes, which may include capital expenditures, commercialization expenditures, research and development expenditures, regulatory   
 affairs expenditures, clinical trial expenditures, acquisitions of new technologies and investments, business combinations and the repayment, refinancing, redemption or repurchase of indebtedness or capital stock. See “Use of                      
 Proceeds” elsewhere in this prospectus.                                                                                                                                                                                                                |

| Market for our Common Stock | Our Common Stock is listed on the Nasdaq Capital Market under the symbol “SCLX”. |

| Risk factors | See “Risk Factors” beginning on page 23 and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in the securities being offered by this prospectus. |

| (1) | The number of shares of Common Stock outstanding assumes that an aggregate of 6,951,671 shares are outstanding                                                                                         
 immediately prior to the completion of this offering, which number is based on an aggregate of 6,951,671 shares outstanding as of December 31